Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent Asserted Against Hologic; The U.S. Court Of Appeals Rejected Minerva’s Arguments On Appeal And As A Result, Minerva Had To Pay Hologic More Than $7.4M
Hologic, Inc. (NASDAQ:HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a 2021 district court ruling that invalidated a Minerva patent asserted against Hologic. The
